Wearable to Power Remote Care and Clinical Trials
Within a few weeks of announcing FDA clearance and the launch of BioSticker, a single-use wearable for monitoring patient health, BioIntelliSense Inc. reports the sensor will be employed in two different remote patient monitoring programs.
The FDA-cleared BioSticker medical device is designed to be worn comfortably on the upper left chest for effortless continuous vital sign monitoring for up to 30 days on a single use device, Jim Mault, CEO of BioIntelliSense, told MD+DI. âBioSticker device allows for the continuous remote monitoring of a patientâs vital signsârespiratory rate at rest, heart rate at rest, and skin temperatureâalong with other parameters like activity levels, body position, and gait analysis. The simple âstick it on and forget itâ patient experience allows for remote data capture and reporting to enable personalized clinical intelligence.â Mault said that clinical applications span pre-surgical baseline assessments, condition management screening, and active remote patient monitoring (RPM) of complex care patients.
The physician-prescribed BioSticker is being used as part of a strategic collaboration with UCHealth and its CARE Innovation Center to clinically validate and to develop a continuous care model that extends beyond the walls of the hospital, Mault said.
Dr. Richard Zane, UCHealth Chief Innovation Officer and Chair of Emergenc...
Source: MDDI - Category: Medical Devices Authors: Daphne Allen Tags: Digital Health Source Type: news
More News: Anesthesia | Anesthesiology | Cardiology | Clinical Trials | Emergency Medicine | Heart | Hospitals | Medical Devices | Orthopaedics | Rehabilitation | Respiratory Medicine | Skin